Alcohol withdrawal: Inpatient management: Difference between revisions

(Created page with "==Management== ==External Links== ==References== <references/>")
 
No edit summary
Line 1: Line 1:
==Management==
==Management==
''Start aggressive [[Benzodiazepines|Benodiazepine]] therapy at CIWA score of 8. Consider ICU admission with score >20''
===[[Benzodiazepines]]===
*[[Diazepam]] (Valium) 5-10mg IV (depending on severity)
**May repeat q5-10min for severe withdrawal (double dose until desired effect achieved)
*[[Lorazepam]] (Ativan) 1-4mg IV (depending on severity)
**May repeat q15-20min for severe withdrawal (titrated to effect)
**Rarely causes hepatitis, as opposed to diazepam which may cause a cholestatic hepatitis<ref>National Institute of Diabetes and Digestive and Kidney Diseases. Lorazepam Drug Record. http://livertox.nih.gov/Lorazepam.htm</ref>
===Alpha-2 agonists ([[Dexmedetomidine]])===
*Decrease severity of sxs, but only supplemental to GABA-ergic first-lines
* Dexmedetomidine drip, start 0.2 mcg/kg/min, likely needing no more than 0.7 mcg/kg/min
===[[Barbituates]] ([[Phenobarbital]])===
*Used when refractory to [[benzodiazepines]]
* [[Phenobarbital]] 130-260 mg IV q 15-20 minutes


==External Links==
==External Links==

Revision as of 17:28, 15 February 2016

Management

Start aggressive Benodiazepine therapy at CIWA score of 8. Consider ICU admission with score >20

Benzodiazepines

  • Diazepam (Valium) 5-10mg IV (depending on severity)
    • May repeat q5-10min for severe withdrawal (double dose until desired effect achieved)
  • Lorazepam (Ativan) 1-4mg IV (depending on severity)
    • May repeat q15-20min for severe withdrawal (titrated to effect)
    • Rarely causes hepatitis, as opposed to diazepam which may cause a cholestatic hepatitis[1]

Alpha-2 agonists (Dexmedetomidine)

  • Decrease severity of sxs, but only supplemental to GABA-ergic first-lines
  • Dexmedetomidine drip, start 0.2 mcg/kg/min, likely needing no more than 0.7 mcg/kg/min

Barbituates (Phenobarbital)

External Links

References

  1. National Institute of Diabetes and Digestive and Kidney Diseases. Lorazepam Drug Record. http://livertox.nih.gov/Lorazepam.htm